NCT00003003View on ClinicalTrials.gov

Mitomycin and Mitoxantrone in Treating Patients With Acute Myelogenous Leukemia

PHASE1CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

September 30, 1996

Primary Completion Date

August 31, 2000

Study Completion Date

August 31, 2000

Conditions
Leukemia
Interventions
BIOLOGICAL

sargramostim

DRUG

mitomycin C

DRUG

mitoxantrone hydrochloride

Trial Locations (1)

03756

Norris Cotton Cancer Center, Lebanon

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Dartmouth-Hitchcock Medical Center

OTHER

NCT00003003 - Mitomycin and Mitoxantrone in Treating Patients With Acute Myelogenous Leukemia | Biotech Hunter | Biotech Hunter